People struggling with obesity can now reliably lose weight thanks to the emergence of GLP-1 drugs like semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. Unfortunately, recent research finds that GLP-1 users might also lose respect from others, too. Scientists at Rice University studied how volunteers reacted to various fictional scenarios about an obese person. People were on average harsher toward those who lost weight via GLP-1 drugs than toward those who lost weight through diet and exercise alone, the researchers found. Remarkably, they were even meaner to GLP-1 users than to obese people who hadn’t lost any weight at all. The findings suggest that some people are especially judgmental about GLP-1 drugs and the people who take them. “As GLP-1s have gained popularity, people have begun to stigmatize those who lose weight using GLP-1s,” the authors wrote in their paper, published last month in the International Journal of Obesity.…